Fundsmith 13F: Cuts Doximity (DOCS) Stake by $19M

Fundsmith Scales Back Doximity, Inc. Holdings

Fundsmith pared down its investment in Doximity, Inc. NYSE:DOCS according to a recent Form 13F filing with the Securities and Exchange Commission. The fund cut its stake by 58.1%, offloading 958,216 shares during the period. Institutional filings provide a backward-looking snapshot of holdings as of the reporting date and may not reflect current positions.

Trimming the Stake in Doximity Stock

Before the recent reduction, Fundsmith held 1,650,002 shares of the health information platform. The sale of 958,216 shares left the fund with 691,786 shares. Based on market prices around the filing date, the remaining stake carried a value of approximately $13.86 million.

Doximity Stock Trades Lower Amid Market Shifts

Doximity stock recently traded around $20.04, sitting well below its 52-week high of $76.51 and closer to its low of $17.15. The shares trade below both their 50-day moving average of $24.10 and their 200-day moving average of $27.66. The company carries a forward P/E ratio of 17.32 based on upcoming earnings estimates.

Analysts Set New Price Targets

Wall Street firms have kept a close eye on the digital platform for medical professionals, adjusting targets through late summer and autumn. On September 29, 2026, Evercore ISI Group maintained its In-Line rating while lowering its price target to $35.00 from $40.00. Earlier, on September 8, 2026, Freedom Capital Markets downgraded the stock to Hold with a target of $27.00. Barclays maintained an Equal-Weight rating with a $27.00 target on August 21, 2026, and Truist Securities kept a Hold rating with a $24.00 target on August 13, 2026. Wells Fargo issued an Underweight rating with an $18.00 target on August 10, 2026. JP Morgan kept a Neutral rating and set a $31.00 target on August 7, 2026, while Piper Sandler reiterated an Overweight rating with a $47.00 target on the same day. Overall, the stock carries a consensus hold rating from eighteen analysts, with a mean price target of $29.94.

Inside Doximity and Its Digital Platform

Doximity, Inc. runs a digital network for doctors, nurse practitioners, and other medical professionals in the United States. The platform offers clinical news feeds, telehealth tools, and AI-powered workflow assistants like Scribe and Ask to help clinicians manage schedules and paperwork. Founded in 2010 and based in San Francisco, the company connects healthcare providers with peers and pharmaceutical manufacturers.

What to Watch Next for Doximity

Investors tracking Doximity will look toward the company's next earnings report, scheduled for November 5, 2026. Future SEC filings will show whether other major institutional investors continue to adjust their stakes in the healthcare technology provider.